Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2023

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Spain in Key Global Trial Studying Berubicin for Treatment of GBM

Posted on February 7, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that enrollment is continuing in its ongoing global trial evaluating Berubicin for the treatment of … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Reports Key Advantages of McEwen Copper’s Los Azules Project

Posted on February 7, 2023 by MissionIR

McEwen Mining (NYSE: MUX) (TSX: MUX), an asset-rich diversified gold and silver producer in the Americas, with large exposure to copper through its 68-percent-owned subsidiary McEwen Copper, has reported rich copper values over attractive widths, resulting from infill drilling at … Continue reading →

Posted in McEwen Mining Inc. MUX | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Robot Roadshow to Take the Spotlight in Vegas

Posted on February 6, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, today announced that its Robot Roadshow will land at Silverton Hotel & Casino in Las Vegas, Nevada, from 10:00 a.m. to 2:00 p.m. PT on Feb. 7-9, 2023. The engaging … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Grants RSUs as Part of Long-Term Incentive Plan

Posted on February 6, 2023 by MissionIR

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, recently announced that it has granted an aggregate of 300,000 restricted share units … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Animal Study Results Featured in Aegis Capital Corp. Updated Price Target

Posted on February 6, 2023 by MissionIR

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is the subject of an updated report released from Aegis Capital Corp. The update reflects … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Successful Capital Raising; Net Proceeds Will Be Destined Towards Ongoing Bolivian Mining Operations

Posted on February 6, 2023 by MissionIR

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, announced that it had successfully concluded its previously announced, fully-underwritten primary share placement … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

MissionIRNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Wins Largest Commercial Lidar Deployment Contract in Tolling Sector to Date

Posted on February 6, 2023 by MissionIR

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has been awarded a multimillion sales contract from one of the leading U.S. highway tolling systems in the country. The company announced that its exclusive, state-of-the-art lidar solution … Continue reading →

Posted in Cepton Inc. CPTN | Leave a comment

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Aiming to Capture Significant Market Share for Treatment and Prevention of COVID-19 Illness with Innovative Inhaled NanoAb

Posted on February 6, 2023 by MissionIR

The Food and Drug Administration (“FDA”) recently withdrew the authorization of AstraZeneca PLC (NASDAQ: AZN)’s Evusheld, a combination of two monoclonal antibodies (“mAbs”), which was being marketed as a pre-exposure prophylaxis to prevent COVID-19 infection among people with moderate to … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) To Intensify Focus on Commercial Execution of its DehydraTECH Technology for the 2023 Calendar year

Posted on February 6, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has set its focus on the commercial execution of its robust patented DehydraTECH(TM) technology portfolio for the 2023 calendar year. The company plans to capitalize on the success of … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Helping Companies to Affordably Transition from Dependence on Carbon Fuel

Posted on February 3, 2023 by MissionIR

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled distributed energy solutions company, foresees exciting new opportunities available thanks to the government’s emphasis on driving the country toward a future free of its dependence on carbon fuel and otherwise inefficient utilities. “Correlate … Continue reading →

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment